Medtech Insight News Today

ReWalk has completed the acquisition of AlterG, which provides anti-gravity systems for use in physical and neurological rehabilitation.

Nutromics raises $14M to develop lab-on-a-patch DNA microneedle sensor that monitors biomarkers in interstitial fluid.

After a nine month wait, a seventh Notified Body has at last been designated under the EU’s new In Vitro Diagnostic Medical Device Regulation (IVDR)…

To embed, copy and paste the code into your website or blog: In the past week, the FDA revealed the future plan for its inspectional activities. In addition, President Biden announced a new July 4 vaccination target. Please see details for these and other supply chain developments below: On April 27, Medtech Insight posted an FDA document to a medical device firm, explaining the Office of Medical Device and Radiological Health Operations’ Remote Regulatory Assessment (RRA) program to determin...

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19 by Zach Henderson, Chief Commercial Officer, Glooko Zach Henderson, Chief Commercial Officer, Glooko As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safel...